Skip to main content

Advertisement

Contact Romain Schollhammer

From: Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples

Contact corresponding author